AI And Healthcare TechnologyTempus AI is positioned at the forefront of the intersection between diagnostics and AI, enabling AI-driven precision medicine.
Revenue GrowthTempus reiterated its goal to deliver consistent 25% growth at scale over a multi-year period, with increased confidence in its ability to execute this trajectory.
Strategic CollaborationsStrategic acquisitions and collaborations, such as the acquisition of Ambry Genetics and partnerships with AstraZeneca and Pathos AI, are expected to boost topline growth.